Search Results 721-730 of 2925 for ⚖올인구조대 【위너보증.com / 가입코드 9122】 토지노추천 ⚖

  1. Towards Precise and Rapid Diagnosis of Heparin-Induced Thrombocytopenia: a Prospective, Multicentre Cohort Study (“TORADI-HIT”) - Mayo Clinic

    Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to ...

  2. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

    1 in subjects with inoperable or advanced intrahepatic cholangiocarcinoma (iCCA) whose tumors harbor FGFR2 gene fusions (by FISH performed by the central ...

  3. Androgen Deprivation To Enrich PSMA Expression And Improve Sensitivity Of Staging PSMA PET/C - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  4. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  5. Gastroenterology and Hepatology - Clinical trials

    One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. The purpose of this study ...

  6. Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma - Mayo Clinic

    Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to ...

  7. An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia - Mayo Clinic

    ... no treatment and AZA administered for 7 days of each cycle. Study treatment should continue until there is documented disease progression, relapse from ...

  8. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to ...

  9. A Study to Evaluate Performance of Coagulation Laboratory Testing in Children and Young Adults - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  10. A Study to Evaluate Return of Pharmacogenomic Results Through Direct-to-Consumer Online Portal: Consumer Experiences - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...